Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 27
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Culture-Free Sequencing of Mycobacterium Tuberculosis for Diagnosis and Genetic Diversity Identification

  • Mariner Llicer, Carla
[ES] La detección y diagnóstico de resistencias en Mycobacterium tuberculosis (MTB) supone un reto para el control de la tuberculosis (TB). La técnica diagnóstica implica el cultivo de muestras diagnósticas, pero este proceso es lento y retrasa los resultados hasta meses demorando la prescripción del tratamiento óptimo. El cultivo también se utiliza para enriquecer muestras diagnósticas con fines de investigación, como la secuenciación del genoma de MTB. Sin embargo, se desconoce si cultivar reduce la diversidad genética de la muestra diagnóstica, sesgando los resultados. Actualmente, las técnicas moleculares permiten evitar el cultivo en el diagnóstico, detectando resistencia a antibióticos más rápidamente, pero se limitan a identificar las mutaciones comunes asociadas a la resistencia a la rifampicina (RIF) e isoniazida (INH), los fármacos de primera línea. No obstante, la composición compleja de las muestras diagnósticas como el esputo sigue siendo un desafío para la secuenciación. Esta tesis presenta técnicas y estrategias de secuenciación para recuperar MTB a partir de esputos, centrándose en la diversidad genética en esputos y cultivos y explorando el potencial de la secuenciación para determinar resistencias. En el Capítulo 1 comparamos la diversidad genética entre pares de esputos y cultivos en dos entornos diferentes. Desarrollamos una técnica de secuenciación de esputos, realizando una secuenciación directa o enriquecida según la cantidad de MTB presente. Además, implementamos un flujo de análisis para descartar artefactos del procesamiento de muestras. Los resultados muestran una alta concordancia en la diversidad entre esputos y cultivos, cuestionando la hipótesis inicial del cuello de botella en el cultivo. En el Capítulo 2 exploramos las limitaciones del Gene Xpert MTB/RIF Ultra (XpertUltra) para identificar mutaciones de resistencia a RIF, examinando las mutaciones de resistencia más prevalentes en el sur de Mozambique. Utilizamos la secuenciación del genoma completo para identificar variantes de resistencia en cepas recolectadas en Manhiça, Mozambique. Detectamos dos cepas con mutaciones de resistencia a RIF no identificadas por el XpertUltra y una alta prevalencia de cepas resistentes a INH sin resistencia a RIF (no multirresistentes, MDR). Los resultados sugieren que el XpertUltra podría no detectar algunos casos de resistencia a RIF y/o INH, destacando la necesidad de incluir nuevas mutaciones en las pruebas moleculares. En el Capítulo 3 evaluamos el potencial de la secuenciación de amplicones para predecir la resistencia a antibióticos e identificar el linaje de las cepas. Diseñamos un panel de nueve genes asociados a la resistencia a siete antibióticos y dos regiones filogenéticas, poniendo a punto una PCR multiplex para amplificar todas las regiones en una sola reacción. A diferencia de otros paneles, los cebadores diseñados cubren los genes completos para detectar todas las mutaciones presentes. La secuenciación se realiza con MinION (Nanopore), una plataforma portátil con análisis en tiempo real. Comparamos las variantes obtenidas con las de Illumina para calibrar los parámetros del llamado de variantes y evitar falsos positivos. Los resultados muestran una alta correlación entre MinION e Illumina en la detección de resistencia e identificación de linajes, independientemente del tipo de muestra. Estos resultados, junto con el análisis en tiempo real de MinION, son prometedores para su implementación en atención primaria. En conclusión, esta tesis contribuye a los avances en la genómica de muestras diagnósticas. Por un lado, demostrando que el cultivo refleja la diversidad genética del esputo, y por otro, revelando el potencial de la secuenciación del genoma y de amplicones para predecir resistencia a antibióticos. Las técnicas y resultados que se presentan contribuirán a promover la secuenciación directa de esputo como técnica de diagnóstico rápida y precisa, pero también su uso para la investigación., [CA] La detecció i diagnòstic de resistències en Mycobacterium tuberculosis (MTB) suposa un repte per al control de la tuberculosi (TB). La tècnica de referència ha estat el cultiu de mostres diagnòstiques, però aquest procés és lent, retardant els resultats durant setmanes o mesos i dificultant la prescripció d'un tractament òptim. El cultiu també s'ha utilitzat per enriquir mostres diagnòstiques amb finalitats de recerca, com la seqüenciació del genoma de MTB. No obstant això, encara es desconeix si el cultiu redueix la diversitat genètica de la mostra diagnòstica, cosa que podria generar un biaix en els resultats. Actualment, les tècniques moleculars han permès evitar el cultiu en el diagnòstic, detectant resistència a antibiòtics més ràpidament, però es limiten a identificar les mutacions comunes associades a resistència a la rifampicina (RIF) i isoniazida (INH), els fàrmacs de primera línia. Tanmateix, la composició complexa de les mostres diagnòstiques com l'esput segueix sent un repte per a la seqüenciació. Aquesta tesi presenta tècniques i estratègies de seqüenciació per recuperar MTB a partir d'esputs, centrant-se en la diversitat genètica en esputs i cultius i explorant el potencial de la seqüenciació per determinar resistències. Al Capítol 1 comparem la diversitat genètica entre parelles d'esputs i cultius en dos entorns diferents. Desenvolupem una tècnica de seqüenciació d'esputs, realitzant una seqüenciació directa o enriquida segons la quantitat de MTB present. A més, implementem un flux d'anàlisi per descartar artefactes del processament de mostres. Els resultats mostren una alta concordança en la diversitat entre esputs i cultius, qüestionant la hipòtesi inicial d'un coll de botella al cultiu. Al Capítol 2 explorem les limitacions de la prova molecular Gene Xpert MTB/RIF Ultra (XpertUltra) per identificar mutacions de resistència a RIF, examinant les mutacions de resistència més prevalents al sud de Moçambic. Utilitzem la seqüenciació del genoma complet per identificar variants de resistència a antibiòtics en soques recol·lectades a Manhiça, Moçambic. Detectem dues soques amb mutacions de resistència a rifampicina no identificades per l'XpertUltra i una alta prevalença de soques resistents a INH sense resistència a RIF (no multiressistents, MDR). Els resultats sugereixen que l'XpertUltra pot no detectar alguns casos de resistència a RIF i/o INH, destacant la necessitat d'incloure noves mutacions en proves moleculars. Al Capítol 3 avaluem el potencial de la seqüenciació d'amplicons per predir resistència a antibiòtics i identificar el llinatge de les soques. Dissenyem un panell de nou gens associats a resistència a set antibiòtics i dues regions filogenètiques, posant a punt una PCR multiplex per amplificar totes les regions en una sola reacció. A diferència d'altres panells, els encebadors dissenyats cobreixen els gens complets, per detectar totes les mutacions presents. La seqüenciació es realitza amb MinION (Nanopore), una plataforma portàtil amb anàlisi en temps real. Comparem les variants obtingudes amb les d'Illumina per calibrar paràmetres per cridar de variants i evitar falsos positius. Els resultats mostren una alta correlació entre MinION i Illumina en la detecció de resistència i identificació de llinatges, independentment del tipus de mostra. Aquests resultats, juntament amb l'anàlisi en temps real de MinION, són prometedors per a la seva implementació en atenció primària. En conclusió, aquesta tesi contribueix als avanços en la genòmica directa de mostra diagnòstica. D'una banda, demostrant que el cultiu reflecteix la diversitat genètica de l'esput i, d'altra banda, revelant el potencial de la seqüenciació del genoma i d'amplicons per predir resistència a antibiòtics. Els resultats obtinguts superen les limitacions de les proves moleculars actuals, i les tècniques presentades podrien promoure la seqüenciació directa d'esput com a eina de diagnòstic ràpida i precisa, així com per a la investigació., [EN] Mycobacterium tuberculosis (MTB) detection and diagnosis of drug resistance(DR) have been a challenge for tuberculosis(TB) control. Culturing mycobacteria from diagnostic samples has been the most commonly used diagnostic technique. However, culturing depends on MTB's slow growth, delaying results and the prescription of optimal treatment for weeks to months. Culture is also essential for research purposes such as MTB genomics. However, it remains unclear whether it causes a bottleneck in the sample's original genetic diversity, potentially biasing results. Skipping the culturing step has been possible with the introduction of molecular techniques in surveillance systems. These reduce turnaround time and allow MTB and DR detection through a single assay. However, such tests are limited to detecting common mutations associated with rifampicin(RIF) and isoniazid(INH) resistance. Moreover, the complex composition of diagnostic samples, like sputum, continues to challenge sequencing workflows in research. In this thesis, we explore different sequencing approaches to recover and sequence MTB from sputum samples, focusing on overcoming the hypothesized culture bottleneck and evaluating the potential of sequencing for DR prediction. In Chapter 1, we compare genetic diversity within sputum-culture paired samples in two settings. We implement a culture-free sequencing (cfWGS) approach for sputum, using both direct and enriched sequencing, depending on the initial amount of MTB DNA. We also develop an analysis pipeline to filter artifactual variants from cfWGS approaches. To generalize results, three additional datasets are reanalyzed. The results show high concordance in genetic diversity between sputum-culture pairs, both in terms of presence and frequency of variants. These results contradict the initial culture bottleneck assumption, emphasizing the importance of tailored filtering steps depending on sample complexity. In Chapter 2, we explore the limitations of the Gene Xpert MTB/RIF Ultra (XpertUltra) for detecting non-common mutations and screen for prevalent DR mutations in southern Mozambique. We use WGS to identify DR variants in strains collected in Manhiça (Mozambique) during two time periods. Two strains were found to harbor RIF resistance mutations beyond XpertUltra's detection scope. We also detect a high prevalence of INH-resistant strains without RIF resistance (non-MDR TB). This suggests that XpertUltra, the primary diagnostic tool in the region, sometimes misclassifies RIF-resistant cases, highlighting the need for expanded drug and mutation coverage in molecular diagnostic tests. In Chapter 3, we assess the potential of targeted sequencing for DR prediction and lineage identification by designing a gene panel of 9 genes associated with resistance to 7 drugs and two phylogenetic regions. We develop a multiplex PCR to amplify all target regions in one reaction. Unlike other commercial panels, our primers cover entire genes allowing the identification of all mutations, not just those in hotspot regions. We employ the portable MinION (Nanopore) platform, which provides real-time analysis. A key aim is to calibrate parameters for MinION variant calling by comparing its results to Illumina sequencing, establishing a frequency cut-off to avoid false positives due to MinION's error rate. Our results show high concordance between MinION and Illumina in detecting DR and genotyping, regardless of the sample type. These findings present a significant advantage for future implementation in point-of-care systems. This thesis advances the field of cfWGS by confirming that culture mirrors sputum's genetic diversity and demonstrating the potential of whole genome and targeted sequencing to overcome the limitations of current molecular diagnostic tests in predicting DR. The techniques and findings presented could help promote cfWGS as a front-line approach for faster, more accurate diagnosis, and contribute to further research., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00; Fundació La Caixa: HR21-00415, International Science and Technology Center (ISTC): Project #G-2143 and National Institute of Allergy and Infectious Diseases (NIH). This work was also supported by STOP TB partnership [STBP/TBREACH/GSA/W5-30: CA-3-D000920001], the TB Portals programme of the National Institutes of Health, the European Research Council [101001038-TB-RECONNECT: H2020-ERC-COG/0800 and 638553-TB-ACCELERATE], Generalitat Valenciana [AICO/2018/113], the Spanish Ministry of Science and Innovation [PID2019-104477RB-I00] and the Ministerio de Economía, Indústria y Competividad (SAF2016-77346-R)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

  • Miotto, Paolo
  • Comas, Iñaki
  • Rodwell, Timothy C.
Miotto, Paolo. et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354. [https://doi.org/10.1183/13993003.01354-2017]. 13 páginas, 2 figuras, 4 tablas., A clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis is required to accelerate the development of rapid drug susceptibility testing methods based on genetic sequence.Raw genotype-phenotype correlation data were extracted as part of a comprehensive systematic review to develop a standardised analytical approach for interpreting resistance associated mutations for rifampicin, isoniazid, ofloxacin/levofloxacin, moxifloxacin, amikacin, kanamycin, capreomycin, streptomycin, ethionamide/prothionamide and pyrazinamide. Mutation frequencies in resistant and susceptible isolates were calculated, together with novel statistical measures to classify mutations as high, moderate, minimal or indeterminate confidence for predicting resistance.We identified 286 confidence-graded mutations associated with resistance. Compared to phenotypic methods, sensitivity (95% CI) for rifampicin was 90.3% (89.6-90.9%), while for isoniazid it was 78.2% (77.4-79.0%) and their specificities were 96.3% (95.7-96.8%) and 94.4% (93.1-95.5%), respectively. For second-line drugs, sensitivity varied from 67.4% (64.1-70.6%) for capreomycin to 88.2% (85.1-90.9%) for moxifloxacin, with specificity ranging from 90.0% (87.1-92.5%) for moxifloxacin to 99.5% (99.0-99.8%) for amikacin.This study provides a standardised and comprehensive approach for the interpretation of mutations as predictors of M. tuberculosis drug-resistant phenotypes. These data have implications for the clinical interpretation of molecular diagnostics and next-generation sequencing as well as efficient individualised therapy for patients with drug-resistant tuberculosis., This study was supported by tEhe Bill and Melinda Gates Foundation under grant agreement FIND OPP1115209 to address how to score mutations in the ReSeqTB data sharing platform initiative. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. K. Dheda is supported by the South African MRC and the EDCTP. I. Comas is supported by the Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2016–77346-R and the European Research Council (ERC) (638553-TB-ACCELERATE). L. Chindelevitch is supported by a Sloan Fellowship. S. Niemann is supported by grants of the German Center for Infection Research. Funding information for this article has been deposited with the Crossref Funder Registry., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In-Depth Characterization and Functional Analysis of Clonal Variants in a Mycobacterium tuberculosis Strain Prone to Microevolution

  • Navarro, Yurena
  • Pérez-Lago, Laura
  • Herranz, Marta
  • Sierra, Olalla
  • Comas, Iñaki
  • Sicilia, Javier
  • Bouza, Emilio
  • García de Viedma, Darío
The role of clonal complexity has gradually been accepted in infection by Mycobacterium tuberculosis (MTB), although analyses of this issue are limited. We performed an in-depth study of a case of recurrent MTB infection by integrating genotyping, whole genome sequencing, analysis of gene expression and infectivity in in vitro and in vivo models. Four different clonal variants were identified from independent intrapatient evolutionary branches. One of the single-nucleotide polymorphisms in the variants mapped in mce3R, which encodes a repressor of an operon involved in virulence, and affected expression of the operon. Competitive in vivo and in vitro co-infection assays revealed higher infective efficiency for one of the clonal variants. A new clonal variant, which had not been observed in the clinical isolates, emerged in the infection assays and showed higher fitness than its parental strain. The analysis of other patients involved in the same transmission cluster revealed new clonal variants acquired through novel evolutionary routes, indicating a high tendency toward microevolution in some strains that is not host-dependent. Our study highlights the need for integration of various approaches to advance our knowledge of the role and significance of microevolution in tuberculosis., This study was funded by the Ministry of Economy and Competitiveness ISCIII-FIS (PI15/01554) and co-funded by ERDF (FEDER) funds from the European Commission, “A way of making Europe.” Research by YN was supported by a PICATA pre-doctoral fellowship (BE55/11) from the Moncloa Campus of International Excellence (UCM-UPM, Instituto de Investigación Sanitaria Gregorio Marañón). LP-L was supported by a Miguel Servet contract (MS15/00075- CP15/00075). IC lab is financed by Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2013- 43521-R, SAF2016-77346-R, and the European Research Council (ERC) (638553-TB-ACCELERATE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mycobacterium tuberculosis Acquires Limited Genetic Diversity in Prolonged Infections, Reactivations and Transmissions Involving Multiple Hosts

  • Herranz, Marta
  • Pole, Ilva
  • Ozere, Iveta
  • Chiner-Oms, Álvaro
  • Martínez-Lirola, Miguel
  • Pérez-García, Felipe
  • Gijón, Paloma
  • Ruiz Serrano, María Jesús
  • Clotet Romero, Laura
  • Cuevas, Oscar
  • Comas, Iñaki
  • Bouza, Emilio
  • Pérez-Lago, Laura
  • García de Viedma, Darío
9 páginas, 5 figuras y material suplementario en: https://www.frontiersin.org/articles/10.3389/fmicb.2017.02661/full#supplementary-material, Background:Mycobacterium tuberculosis (MTB) has limited ability to acquire variability. Analysis of its microevolution might help us to evaluate the pathways followed to acquire greater infective success. Whole-genome sequencing (WGS) in the analysis of the transmission of MTB has elucidated the magnitude of variability in MTB. Analysis of transmission currently depends on the identification of clusters, according to the threshold of variability (<5 SNPs) between isolates. Objective: We evaluated whether the acquisition of variability in MTB, was more frequent in situations which could favor it, namely intrapatient, prolonged infections or reactivations and interpatient transmissions involving multiple sequential hosts. Methods: We used WGS to analyze the accumulation of variability in sequential isolates from prolonged infections or translations from latency to reactivation. We then measured microevolution in transmission clusters with prolonged transmission time, high number of involved cases, simultaneous involvement of latency and active transmission. Results: Intrapatient and interpatient acquisition of variability was limited, within the ranges expected according to the thresholds of variability proposed, even though bursts of variability were observed. Conclusions: The thresholds of variability proposed for MTB seem to be valid in most circumstances, including those theoretically favoring acquisition of variability. Our data point to multifactorial modulation of microevolution, although further studies are necessary to elucidate the factors underlying this modulation., This study was funded by a grant from the Ministry of Economy and Competitiveness ISCIII FIS (grant 15/01554) and cofunded by ERDF (FEDER) Funds from the European Commission: “A way of making Europe.” IP and IO were supported by the Latvian National Research program VPP 5.7 “BIOMEDICINE.” LP-L was supported by M. Servet contract MS15/00075 and CP15/00075. IC was supported by Ministerio de Educación y Ciencia (Ref SAF2016-77346-R) and the European Research Council (ERC) (638553-TB-ACCELERATE). AC-O is recipient of a FPU fellowship (FPU13/00913) from Ministerio de Educación y Ciencia (Spanish Government)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes

  • Novais Bastos, Helder
  • Osório, Nuno S.
  • Gagneux, Sebastien
  • Comas, Iñaki
  • Saraiva, Margarida
The already enormous burden caused by tuberculosis (TB) will be further aggravated by the association of this disease with modern epidemics, as human immunodeficiency virus and diabetes. Furthermore, the increasingly aging population and the wider use of suppressive immune therapies hold the potential to enhance the incidence of TB. New preventive and therapeutic strategies based on recent advances on our understanding of TB are thus needed. In particular, understanding the intricate network of events modulating inflammation in TB will help to build more effective vaccines and host-directed therapies to stop TB. This review integrates the impact of host, pathogen, and extrinsic factors on inflammation and the almost scientifically unexplored complexity emerging from the interactions between these three factors. We highlight the exciting data showing a contribution of this troika for the clinical outcome of TB and the need of incorporating it when developing novel strategies to rewire the immune response in TB., HN-B acknowledges the receipt of research scholarships from Bolsa D. Manuel de Mello and the Portuguese Society for Pneumology. NO acknowledges FCT IF/00474/2014. SG is funded by the European Research Council (grant number 309540-EVODRTB); the Swiss National Science Foundation (grant number 310030_166687) SystemsX.ch. IC lab is financed by Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2013-43521-R, SAF2016-77346-R, and PROMETEO/2016/122 from Generalitat Valenciana and the European Research Council (ERC) (638553-TB-ACCELERATE). The MS lab is financed by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). MS is an FCT Principal Investigator. Some graphical elements in the figures were designed by kjpargeter/Freepik. The funding agencies had no role in the design of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase

  • Ezewudo, Matthew
  • Borens, Amanda
  • Chiner-Oms, Álvaro
  • Miotto, Paolo
  • Chindelevitch, Leonid
  • Starks, Angela M.
  • Hanna, Debra
  • Liwski, Richard
  • Zignol, Matteo
  • Gilpin, Christopher
  • Niemann, Stefan
  • Kohl, Thomas Andreas
  • Warren, Robin M.
  • Crook, Derrick
  • Gagneux, Sebastien
  • Hoffner, Sven
  • Rodrigues, Camilla
  • Comas, Iñaki
  • Engelthaler, David M
  • Alland, David
  • Rigouts, Leen
  • Lange, Christoph
  • Dheda, Keertan
  • Hasan, Rumina
  • McNerney, Ruth
  • Cirillo, Daniela M.
  • Schito, Marco
  • Rodwell, Timothy C
  • Posey, James
10 Pages, 1 Figure, 3 Tables. Supplementary information: http://dx.doi.org/10.1038/s41598-018-33731-1, Drug-resistant tuberculosis poses a persistent public health threat. The ReSeqTB platform is a collaborative, curated knowledgebase, designed to standardize and aggregate global Mycobacterium tuberculosis complex (MTBC) variant data from whole genome sequencing (WGS) with phenotypic drug susceptibility testing (DST) and clinical data. We developed a unified analysis variant pipeline (UVP) ( https://github.com/CPTR-ReSeqTB/UVP ) to identify variants and assign lineage from MTBC sequence data. Stringent thresholds and quality control measures were incorporated in this open source tool. The pipeline was validated using a well-characterized dataset of 90 diverse MTBC isolates with conventional DST and DNA Sanger sequencing data. The UVP exhibited 98.9% agreement with the variants identified using Sanger sequencing and was 100% concordant with conventional methods of assigning lineage. We analyzed 4636 publicly available MTBC isolates in the ReSeqTB platform representing all seven major MTBC lineages. The variants detected have an above 94% accuracy of predicting drug based on the accompanying DST results in the platform. The aggregation of variants over time in the platform will establish confidence-graded mutations statistically associated with phenotypic drug resistance. These tools serve as critical reference standards for future molecular diagnostic assay developers, researchers, public health agencies and clinicians working towards the control of drug-resistant tuberculosis., This study was supported by the Bill & Melinda Gates Foundation under grant agreement OPP1115887 to C-Path for developing the ReSeqTB drug resistance data sharing platform and under grant agreement FIND OPP1115209 to address how to score mutations in the ReSeqTB data sharing platform initiative. The South African MRC and the EDCTP support K. Dheda. I. Comas is supported by the Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2016-77346-R and the European Research Council (ERC) (638553-TB-ACCELERATE). L. Chindelevitch acknowledges support by NSERC, Genome Canada, and the Sloan Foundation. Use of trade names is for identification only and does not constitute endorsement by the US Department of Health and Human Services, the US Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agency., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing

  • CRyPTIC Consortium and the 100,000 Genomes Project
  • Allix-Beguec, Caroline
  • Arandjelovic, Irena
  • Bi, Lijun
  • Beckert, Patrick
  • Bonnet, Maryline
  • Bradley, Phelim
  • Cabibbe, Andrea M.
  • Cancino-Muñoz, Irving
  • Caulfield, Mark J.
  • Chaiprasert, Angkana
  • Cirillo, Daniela M.
  • Clifton, David A.
  • Comas, Iñaki
  • Crook, Derrick W.
  • De Filippo, Maria R.
  • de Neeling, Han
  • Diel, Roland
  • Drobniewski, Francis A
  • Faksri, Kiatichai
  • Farhat, Maha R.
  • Fleming, Joy
  • Fowler, Philip
  • Fowler, Tom A
  • Gao, Qian
  • Gardy, Jennifer
  • Gascoyne-Binzi, Deborah
  • Gibertoni-Cruz, Ana-Luiza
  • Gil-Brusola, Ana
  • Golubchik, Tanya
  • Gonzalo, Ximena
  • Grandjean, Louis
  • He, Guangxue
  • Guthrie, Jennifer L.
  • Hoosdally, Sarah
  • Hunt, Martin
  • Iqbal, Zamin
  • Ismail, Nazir
  • Johnston, James
  • Khanzada, Faisal M.
  • Khor, Chiea C.
  • Kohl, Thomas A
  • Kong, Clare
  • Lipworth, Sam
  • Liu, Qingyun
  • Maphalala, Gugu
  • Martínez Fernández, Elena
  • Mathys, Vanessa
  • Merker, Matthias
  • Miotto, Paolo
  • Mistry, Nerges
  • Moore, David A. J.
  • Murray, Megan
  • Niemann, Stefan
  • Omar, Shaheed V.
  • Ong, Rick T-H.
  • Peto, Tim E.A.
  • Posey, James E.
  • Prammananan, Therdsak
  • Pym, Alexander
  • Rodrigues, Camilla
  • Rodrigues, Mabel
  • Rodwell, Timothy
  • Rossolini, Gian M.
  • Sanchez Padilla, Elisabeth
  • Schito, Marco
  • Shen, Xin
  • Shendure, Jay
  • Sintchenko, Vitali
  • Sloutsky, Alex
  • Smith, E. Grace
  • Snyder, Matthew
  • Soetaert, Karine
  • Starks, Angela M.
  • Supply, Philip
  • Suriyapol, Prapat
  • Tahseen, Sabira
  • Tang, Patrick
  • Teo, Yik-Ying
  • Thuong, Thuong N. T.
  • Thwaites, Guy
  • Tortoli, Enrico
  • van Soolingen, Dick
  • Walker, A. Sarah
  • Walker, Timothy M.
  • Wilcox, Mark
  • Wilson, Daniel J.
  • Wyllie, David
  • Yang, Yang
  • Zhang, Hongtai
  • Zhao, Yanlin
  • Zhu, Baoli
13 Pages, 1 Figure, 4 tables. The authors’ affiliations are listed in the Supplementary Appendix, available at NEJM.org. Supplementary Material, available at http://dx.doi.org/10.1056/NEJMoa1800474, BACKGROUND: The World Health Organization recommends drug-susceptibility testing of Mycobacterium tuberculosis complex for all patients with tuberculosis to guide treatment decisions and improve outcomes. Whether DNA sequencing can be used to accurately predict profiles of susceptibility to first-line antituberculosis drugs has not been clear. METHODS: We obtained whole-genome sequences and associated phenotypes of resistance or susceptibility to the first-line antituberculosis drugs isoniazid, rifampin, ethambutol, and pyrazinamide for isolates from 16 countries across six continents. For each isolate, mutations associated with drug resistance and drug susceptibility were identified across nine genes, and individual phenotypes were predicted unless mutations of unknown association were also present. To identify how whole-genome sequencing might direct first-line drug therapy, complete susceptibility profiles were predicted. These profiles were predicted to be susceptible to all four drugs (i.e., pansusceptible) if they were predicted to be susceptible to isoniazid and to the other drugs or if they contained mutations of unknown association in genes that affect susceptibility to the other drugs. We simulated the way in which the negative predictive value changed with the prevalence of drug resistance. RESULTS: A total of 10,209 isolates were analyzed. The largest proportion of phenotypes was predicted for rifampin (9660 [95.4%] of 10,130) and the smallest was predicted for ethambutol (8794 [89.8%] of 9794). Resistance to isoniazid, rifampin, ethambutol, and pyrazinamide was correctly predicted with 97.1%, 97.5%, 94.6%, and 91.3% sensitivity, respectively, and susceptibility to these drugs was correctly predicted with 99.0%, 98.8%, 93.6%, and 96.8% specificity. Of the 7516 isolates with complete phenotypic drug-susceptibility profiles, 5865 (78.0%) had complete genotypic predictions, among which 5250 profiles (89.5%) were correctly predicted. Among the 4037 phenotypic profiles that were predicted to be pansusceptible, 3952 (97.9%) were correctly predicted. CONCLUSIONS: Genotypic predictions of the susceptibility of M. tuberculosis to first-line drugs were found to be correlated with phenotypic susceptibility to these drugs. (Funded by the Bill and Melinda Gates Foundation and others.)., Supported by grants from the Bill and Melinda Gates Foundation (OPP1133541, to CRyPTIC, plus separate support to Dr. Rodwell), a Wellcome Trust/Newton Fund–MRC Collaborative Award (200205/Z/15/Z, to CRyPTIC), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) and NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, the NIHR Biomedical Research Centre at Barts, the NIHR Biomedical Research Centre at Imperial, the NIHR and NHS England (to the 100,000 Genomes Project, which is managed by Genomics England, a wholly owned company of the U.K. Department of Health), the Wellcome Trust, the Medical Research Council, Public Health England, a grant from the National Science and Technology Key Program of China (2014ZX10003002), a grant from the National Basic Research program of China (2014CB744403), a grant from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000), a grant from the European Commission Seventh Framework Program (FP7/2007-2013, to Borstel under grant agreement 278864 in the framework of the Patho-NGen-Trace project), the German Center for Infection Research (to Borstel), Leibniz Science Campus Evolutionary Medicine of the Lung (EvoLUNG), the Belgian Ministry of Social Affairs (to the Belgian Reference Center for Tuberculosis and Mycobacteria from Bacterial Diseases Service through a fund within the Health Insurance System), the French governmental program “Investing for the Future” (to Genoscreen), a grant from the European Commission Seventh Framework Program (FP7/2007-2013, to Genoscreen under grant agreement 278864 in the framework of the Patho-NGen-Trace project), grants from the Drug Resistant Tuberculosis Fund (R015833003, to Dr. Chaiprasert), the Faculty of Medicine, Siriraj Hospital, Mahidol University (to Dr. Chaiprasert), a grant from the Ministry of Economy and Competitiveness (MINECO), Spain (SAF2016-77346-R, to Dr. Comas), a grant from the European Research Council (638553-TB-ACCELERATE, to Dr. Comas), a grant from the BC Centre for Disease Control Foundation for Population and Public Health (to Dr. Gardy), a grant from the British Colombia Lung Association (to Dr. Gardy), grants from the Wellcome Trust and the Royal Society (101237/Z/13/Z and 102541/A/13/Z, to Drs. Wilson and Iqbal [Sir Henry Dale Fellows]), a grant from the National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04, to Drs. Ong and Teo), a European Commission Seventh Framework Program European Genetic Network (EUROGEN) grant (201483, to Dr. Drobniewski), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (to Dr. Rodwell). Dr. T. Walker is an NIHR Academic Clinical Lecturer, and Drs. Crook, Peto, and Caulfield are NIHR Senior Investigators. No potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank Stéphanie Duthoy, Carina Hahn, Alamdar Hussain, Yannick Laurent, Mathilde Mairey, Vanessa Mohr, and Mahmood Qadir for technical assistance and George F. Gao, Director of the Chinese Center for Disease Control and Prevention, for directing the Chinese grant and sequencing program, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Whole genome sequencing-based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations

  • Abascal, Estefanía
  • Pérez-Lago, Laura
  • Martínez-Lirola, Miguel
  • Chiner-Oms, Álvaro
  • Herranz, Marta
  • Chaoui, Imane
  • Comas, Iñaki
  • El Messaoudi, My Driss
  • Garrido Cárdenas, José Antonio
  • Santantón, Sheila
  • Bouza, Emilio
  • García de Viedma, Darío
14 páginas, 7 figuras, BackgroundThe analysis of transmission of tuberculosis (TB) is challenging in areas with a large migrant population. Standard genotyping may fail to differentiate transmission within the host country from new importations, which is key from an epidemiological perspective.AimTo propose a new strategy to simplify and optimise cross-border surveillance of tuberculosis and to distinguish between recent transmission in the host country and new importationsMethodsWe selected 10 clusters, defined by 24-locus mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR), from a population in Spain rich in migrants from eastern Europe, north Africa and west Africa and reanalysed 66 isolates by whole-genome sequencing (WGS). A multiplex-allele-specific PCR was designed to target strain-specific marker single nucleotide polymorphisms (SNPs), identified from WGS data, to optimise the surveillance of the most complex cluster.ResultsIn five of 10 clusters not all isolates showed the short genetic distances expected for recent transmission and revealed a higher number of SNPs, thus suggesting independent importations of prevalent strains in the country of origin. In the most complex cluster, rich in Moroccan cases, a multiplex allele-specific oligonucleotide-PCR (ASO-PCR) targeting the marker SNPs for the transmission subcluster enabled us to prospectively identify new secondary cases. The ASO-PCR-based strategy was transferred and applied in Morocco, demonstrating that the strain was prevalent in the country.ConclusionWe provide a new model for optimising the analysis of cross-border surveillance of TB transmission in the scenario of global migration., This project was funded by ISCIII: ERANET-LAC (TRANS-TB-TRANS REF AC16/00057; ELAC2015/T08-0664), FIS (13/01207; 15/01554) and cofunded by ERDF Funds from the European Commission: “A way of making Europe”. Miguel Servet grant (CP15/00075) for LPL. Ministerio de Economía y Competitividad (grant SAF2016-77346-R), ERC (638553-TB-ACCELERATE) to IC. FPU13/00913 (Ministerio de Educación y Ciencia) to ACO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Future of TB Resistance Diagnosis: The Essentials on Whole Genome Sequencing and Rapid Testing Methods

  • Moreno-Molina, Miguel
  • Comas, Iñaki
  • Furió, Victoria
6 páginas, 1 tabla 1 figura, Tuberculosis resistance diagnostics have vastly improved in recent years thanks to the development of standardised phenotypic and molecular testing methods. However, these methods are either slow or limited in the number of resistant genotypes they can detect. With the advent of next-generation sequencing (NGS) we can sidestep all those problems, as we can sequence whole tuberculosis genomes at increasingly smaller costs and requiring less and less DNA. In this review, we explain how accumulated knowledge in the field has allowed us to go from phenotypic testing to molecular methods to Whole Genome Sequencing (WGS) for resistance diagnostics. We compare current diagnostic methods with WGS as to their efficacy in detecting resistant cases, and show how forthcoming advances in NGS technologies will be crucial in widespread implementation of WGS as a diagnostic tool., The authors were supported by the project SAF2016-77346-R, awarded to Iñaki Comas and the grant BES-2017-079656, awarded to Miguel Moreno-Molina by the Spanish Ministry of Economy and Competitiveness., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cryptic resistance mutations associated to misdiagnoses of Multidrug-resistant tuberculosis

  • Cancino-Muñoz, Irving
  • Moreno-Molina, Miguel
  • Furió, Victoria
  • Goig, Galo A.
  • Torres-Puente, Manuela
  • Chiner-Oms, Álvaro
  • Villamayor, Luis M.
  • Sanz, Francisco
  • Guna-Serrano, María Remedio
  • Comas, Iñaki
5 páginas, 2 figuras, Understanding Multidrug-resistant tuberculosis cases not detected by rapid phenotypic and genotypic routine clinical tests is essential to improve diagnostics and advance towards personalized TB treatments. Here, we combine WGS with single-colony phenotyping testing to diagnose a MDR strain infecting a patient over nine years. Our investigation revealed the failure of rapid testing assays and genome-based prediction tools to identify the MDR strain. The false negative outcome was caused by uncommon RIF and INH resistance mutations. Despite WGS data helped to personalize treatment, the patient developed XDR-TB, highlighting the importance of coupling new diagnostic methods with appropriate treatment regimens., This work was supported by the European Research Council (638553-TB-ACCELERATE to I. C.) and the Ministerio de Economía y Competitividad (SAF2016-77346-R to I. C.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Large genomics datasets shed light on the evolution of the Mycobacterium tuberculosis complex

  • Chiner-Oms, Álvaro
  • Comas, Iñaki
Review: 5 páginas, 1 figura, Two strains of Mycobacterium tuberculosis complex can be separated as much as 2500 single nucleotide differences (Coscolla and Gagneux, 2014). In that limited amount of diversity, we find an astonishing range of clinical, epidemiological and biological phenotypes. The most striking is the strong host preferences depending on the infecting strain while more subtle differences can be found looking at different human tuberculosis isolates. Those subtle differences are the most difficult to spot given that analysis methods for so little diversity are limited and phenotypes like virulence are difficult to define and measure. Recent genomics advances allow to study the pathogen diversity at a resolution not available before from comparative species level, to global diversity to transmission in local settings. Here, we will review some of these recent results to highlight how population genomics approaches can aid not only to understand how MTBC evolved but also to identify relevant biomedical targets., IC group is currently funded by projects of the European ResearchCouncil (ERC) research grant 638553-TB-ACCELERATE, Ministerio deEconomía y Competitividad (Spanish Government) research grant SAF2016-77346-R and Consellería de Educació, Investigació, Cultura iEsport (Valencian government) research grant AICO/2018/113. ACO isrecipient of a FPU fellowship from Ministerio de Ciencia, Innovación y Universidades FPU13/00913 (Spanish Government)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic determinants of speciation and spread of the Mycobacterium tuberculosis complex

  • Chiner-Oms, Álvaro
  • Sánchez-Busó, Leonor
  • Corander, Jukka
  • Gagneux, Sebastien
  • Harris, Simon R.
  • Young, D.
  • González-Candelas, Fernando
  • Comas, Iñaki
14 páginas, 6 figuras, Models on how bacterial lineages differentiate increase our understanding of early bacterial speciation events and the genetic loci involved. Here, we analyze the population genomics events leading to the emergence of the tuberculosis pathogen. The emergence is characterized by a combination of recombination events involving core pathogenesis functions and purifying selection on early diverging loci. We identify the phoR gene, the sensor kinase of a two-component system involved in virulence, as a key functional player subject to pervasive positive selection after the divergence of the Mycobacterium tuberculosis complex from its ancestor. Previous evidence showed that phoR mutations played a central role in the adaptation of the pathogen to different host species. Now, we show that phoR mutations have been under selection during the early spread of human tuberculosis, during later expansions, and in ongoing transmission events. Our results show that linking pathogen evolution across evolutionary and epidemiological time scales points to past and present virulence determinants., : This work was funded by projects of the European Research Council (638553-TB-ACCELERATE) and Ministerio de Economía y Competitividad (Spanish government) research grant SAF2016-77346-R (to I.C.); BFU2014-58656-R and BFU2017-89594-R from Ministerio de Economía y Competitividad (Spanish government) and PROMETEO/2016/122 from Generalitat Valenciana (to F.G.-C); and the Swiss National Science Foundation (grants 310030_166687, IZRJZ3_164171, IZLSZ3_170834, and CRSII5_177163), the European Research Council (309540-EVODRTB), and SystemsX.ch (to S.G.). Á.C.-O. is the recipient of an FPU fellowship from Ministerio de Ciencia, Innovación y Universidades FPU13/00913 (Spanish government). L.S.-B. was funded by Wellcome grant number 098051., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genome-wide mutational biases fuel transcriptional diversity in the Mycobacterium tuberculosis complex

  • Chiner-Oms, Álvaro
  • Berney, Michael
  • Boinett, Christine
  • González-Candelas, Fernando
  • Young, Douglas B.
  • Gagneux, Sebastien
  • Jacobs Jr, William R.
  • Parkhill, Julian
  • Cortés, Teresa
  • Comas, Iñaki
11 páginas, 6 figuras., The Mycobacterium tuberculosis complex (MTBC) members display different host-specificities and virulence phenotypes. Here, we have performed a comprehensive RNAseq and methylome analysis of the main clades of the MTBC and discovered unique transcriptional profiles. The majority of genes differentially expressed between the clades encode proteins involved in host interaction and metabolic functions. A significant fraction of changes in gene expression can be explained by positive selection on single mutations that either create or disrupt transcriptional start sites (TSS). Furthermore, we show that clinical strains have different methyltransferases inactivated and thus different methylation patterns. Under the tested conditions, differential methylation has a minor direct role on transcriptomic differences between strains. However, disruption of a methyltransferase in one clinical strain revealed important expression differences suggesting indirect mechanisms of expression regulation. Our study demonstrates that variation in transcriptional profiles are mainly due to TSS mutations and have likely evolved due to differences in host characteristics., This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programmes 638553 (TB-ACCELERATE to I.C.) and 637730 (MtbTransReg to T.C.). M.B. was funded by the National Institute of Health grant AI119573. W.R.J. was funded by the National Institutes of Health grant AI26170. In addition, this work was funded by projects SAF2016-77346-R from Ministerio de Economía y Competitividad (Spanish Government) and AICO/2018/113 from Generalitat Valenciana (to I.C.), BFU2014-58656-R, BFU2017-89594-R from Ministerio de Economía y Competitividad (Spanish Government), PROMETEO/2016/122 from Generalitat Valenciana (to FGC), Wellcome Trust grant 098051 to the Sanger Institute. A.C.O. is recipient of a FPU fellowship from Ministerio de Educación y Ciencia FPU13/00913 (Spanish Government)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development and application of affordable SNP typing approaches to genotype Mycobacterium tuberculosis complex strains in low and high burden countries

  • Cancino-Muñoz, Irving
  • Gil-Brusola, Ana
  • Torres-Puente, Manuela
  • Mariner-Llicer, Carla
  • Dogba, John
  • Akinseye, Victor
  • Adesokan, Kehinde
  • Kwaghe, Ayi
  • Ejeh, Francis
  • Cadmus, Simeon
  • Comas, Iñaki
12 páginas, 6 figuras, 4 tablas, The Mycobacterium tuberculosis complex (MTBC) comprises the species that causes tuberculosis (TB) which affects 10 million people every year. A robust classification of species, lineages, and sub-lineages is important to explore associations with drug resistance, epidemiological patterns or clinical outcomes. We present a rapid and easy-to-follow methodology to classify clinical TB samples into the main MTBC clades. Approaches are based on the identification of lineage and sub-lineage diagnostic SNP using a real-time PCR high resolution melting assay and classic Sanger sequencing from low-concentrated, low quality DNA. Thus, suitable for implementation in middle and low-income countries. Once we validated our molecular procedures, we characterized a total of 491 biological samples from human and cattle hosts, representing countries with different TB burden. Overall, we managed to genotype ~95% of all samples despite coming from unpurified and low-concentrated DNA. Our approach also allowed us to detect zoonotic cases in eight human samples from Nigeria. To conclude, the molecular techniques we have developed, are accurate, discriminative and reproducible. Furthermore, it costs less than other classic typing methods, resulting in an affordable alternative method in TB laboratories., This work was supported by European Research Council (grant, 638553-TB-ACCELERATE) and the Ministerio de Economía y Competitividad grants (SAF2013-43521-R and SAF2016-77346-R) both to I.C., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain

  • Xu, Yuanwei
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borrás, Rafael
  • Borrás-Máñez, María
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodríguez, Oscar
  • Gil-Brusola, Ana
  • Gimeno, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Bárbara
  • González-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • Colijn, Caroline
  • Comas, Iñaki
Artículo con 20 páginas, 5 figuras, 1 tabla. All the sequence data are deposited in the European Nucleotide Archive under the Bioproject number PRJEB29604 (https://www.ebi.ac.uk/ena/data/view/PRJEB29604) and the accession numbers ERR2099780 (https://www.ebi.ac.uk/ena/data/search?query=ERR2099780) and ERR2099784 (https://www.ebi.ac.uk/ena/data/search?query=ERR2099784)., BACKGROUND: Whole genome sequencing provides better delineation of transmission clusters in Mycobacterium tuberculosis than traditional methods. However, its ability to reveal individual transmission links within clusters is limited. Here, we used a 2-step approach based on Bayesian transmission reconstruction to (1) identify likely index and missing cases, (2) determine risk factors associated with transmitters, and (3) estimate when transmission happened. METHODS AND FINDINGS: We developed our transmission reconstruction method using genomic and epidemiological data from a population-based study from Valencia Region, Spain. Tuberculosis (TB) incidence during the study period was 8.4 cases per 100,000 people. While the study is ongoing, the sampling frame for this work includes notified TB cases between 1 January 2014 and 31 December 2016. We identified a total of 21 transmission clusters that fulfilled the criteria for analysis. These contained a total of 117 individuals diagnosed with active TB (109 with epidemiological data). Demographic characteristics of the study population were as follows: 80/109 (73%) individuals were Spanish-born, 76/109 (70%) individuals were men, and the mean age was 42.51 years (SD 18.46). We found that 66/109 (61%) TB patients were sputum positive at diagnosis, and 10/109 (9%) were HIV positive. We used the data to reveal individual transmission links, and to identify index cases, missing cases, likely transmitters, and associated transmission risk factors. Our Bayesian inference approach suggests that at least 60% of index cases are likely misidentified by local public health. Our data also suggest that factors associated with likely transmitters are different to those of simply being in a transmission cluster, highlighting the importance of differentiating between these 2 phenomena. Our data suggest that type 2 diabetes mellitus is a risk factor associated with being a transmitter (odds ratio 0.19 [95% CI 0.02-1.10], p < 0.003). Finally, we used the most likely timing for transmission events to study when TB transmission occurred; we identified that 5/14 (35.7%) cases likely transmitted TB well before symptom onset, and these were largely sputum negative at diagnosis. Limited within-cluster diversity does not allow us to extrapolate our findings to the whole TB population in Valencia Region. CONCLUSIONS: In this study, we found that index cases are often misidentified, with downstream consequences for epidemiological investigations because likely transmitters can be missed. Our findings regarding inferred transmission timing suggest that TB transmission can occur before patient symptom onset, suggesting also that TB transmits during sub-clinical disease. This result has direct implications for diagnosing TB and reducing transmission. Overall, we show that a transition to individual-based genomic epidemiology will likely close some of the knowledge gaps in TB transmission and may redirect efforts towards cost-effective contact investigations for improved TB control., IC was supported by European Research Council (638553-TB-ACCELERATE), the Ministerio de Economía y Competitividad (SAF2016-77346-R). CC and YX were supported by the Engineering and Physical Sciences Research Council of the UK (EPSRC EP/K026003/1 (CC) and EPSRC EP/N014529/1 (CC and YX)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Towards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics

  • Goig, Galo A.
  • Torres-Puente, Manuela
  • Mariner-Llicer, Carla
  • Villamayor, Luis M.
  • Chiner-Oms, Álvaro
  • Gil-Brusola, Ana
  • Borrás, Rafael
  • Comas, Iñaki
5 páginas, 2 figuras. AVAILABILITY AND IMPLEMENTATION: The database of non-tuberculous mycobacteria assemblies can be accessed at: 10.5281/zenodo.3374377. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online: http://dx.doi.org/10.1093/bioinformatics/btz729, MOTIVATION: Tuberculosis (TB) remains one of the main causes of death worldwide. The long and cumbersome process of culturing Mycobacterium tuberculosis complex (MTBC) bacteria has encouraged the development of specific molecular tools for detecting the pathogen. Most of these tools aim to become novel TB diagnostics, and big efforts and resources are invested in their development, looking for the endorsement of the main public health agencies. Surprisingly, no study has been conducted where the vast amount of genomic data available is used to identify the best MTBC diagnostic markers. RESULTS: In this work, we used large-scale comparative genomics to identify 40 MTBC-specific loci. We assessed their genetic diversity and physiological features to select 30 that are good targets for diagnostic purposes. Some of these markers could be used to assess the physiological status of the bacilli. Remarkably, none of the most used MTBC markers is in our catalog. Illustrating the translational potential of our work, we develop a specific qPCR assay for quantification and identification of MTBC DNA. Our rational design of targeted molecular assays for TB could be used in many other fields of clinical and basic research., This work was supported by projects of the European Research Council (ERC) (638553-TB-ACCELERATE), Ministerio de Economía y Competitividad and Ministerio de Ciencia, Innovación y Universidades (Spanish Government), SAF2013-43521-R, SAF2016-77346-R and SAF2017–92345–EXP (to I.C.), BES-2014-071066 (to G.A.G.), FPU 13/00913 (to A.C.O.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events

  • López, Mariana G.
  • Dogba, John B.
  • Torres-Puente, Manuela
  • Goig, Galo A.
  • Moreno-Molina, Miguel
  • Villamayor, Luis M.
  • Cadmus, Simeon
  • Comas, Iñaki
12 páginas, 5 figuras, 2 tablas. DNA sequences generated as part of this study have been deposited at the European Nucleotide Archive under study accession number PRJEB32589 (Table S1) (2019), Tuberculosis (TB) surveillance is scarce in most African countries, even though it is the continent with the greatest disease incidence according to the World Health Organization. Liberia is within the 30 countries with the highest TB burden, probably as a consequence of the long civil war and the recent Ebola outbreak, both crippling the health system and depreciating the TB prevention and control programmes. Due to difficulties working in the country, there is a lack of resistance surveys and bacillus characterization. Here, we use genome sequencing of Mycobacterium tuberculosis clinical isolates to fill this gap. Our results highlight that the bacillus population structure is dominated by lineage 4 strains that harbour an outstanding genetic diversity, higher than in the rest of Africa as a whole. Coalescent analyses demonstrate that strains currently circulating in Liberia were introduced several times beginning in the early year 600 CE until very recently coinciding with migratory movements associated with the civil war and Ebola epidemics. A higher multidrug-resistant (MDR)-TB frequency (23.5 %) than current estimates was obtained together with non-catalogued drug-resistance mutations. Additionally, 39 % of strains were in genomic clusters revealing that ongoing transmission is a major contribution to the TB burden in the country. Our report emphasizes the importance of TB surveillance and control in African countries where bacillus diversity, MDR-TB prevalence and transmission are coalescing to jeopardize TB control programmes., This work was supported by the European Research Council (638553-TB-ACCELERATE) and the Ministerio de Economía y Competitividad (SAF2013-43521-R and SAF2016-77346-R to I.C.). Funding support from the John D. and Catherine T. MacArthur Foundation, USA, under the Higher Education Initiative in Africa (grant no. 97944-0-800/406/99) for the establishment of the Center for Control and Prevention of Zoonoses, University of Ibadan, Nigeria, is appreciated., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Specificity and mutagenesis bias of the mycobacterial alternative mismatch repair analyzed by mutation accumulation studies

  • Castañeda-García, A.
  • Martín-Blecua, Isabel
  • Cebrián-Sastre, E.
  • Chiner-Oms, Álvaro
  • Torres-Puente, Manuela
  • Comas, Iñaki
  • Blázquez, J.
10 páginas, 3 figuras, 3 tablas. Material suplementario en: https://advances.sciencemag.org/content/suppl/2020/02/10/6.7.eaay4453.DC1, The postreplicative mismatch repair (MMR) is an almost ubiquitous DNA repair essential for maintaining genome stability. It has been suggested that Mycobacteria have an alternative MMR in which NucS, an endonuclease with no structural homology to the canonical MMR proteins (MutS/MutL), is the key factor. Here, we analyze the spontaneous mutations accumulated in a neutral manner over thousands of generations by Mycobacterium smegmatis and its MMR-deficient derivative (ΔnucS). The base pair substitution rates per genome per generation are 0.004 and 0.165 for wild type and ΔnucS, respectively. By comparing the activity of different bacterial MMR pathways, we demonstrate that both MutS/L- and NucS-based systems display similar specificity and mutagenesis bias, revealing a functional evolutionary convergence. However, NucS is not able to repair indels in vivo. Our results provide an unparalleled view of how this mycobacterial system works in vivo to maintain genome stability and how it may affect Mycobacterium evolution., This work was supported by Plan Nacional de I + D + i 2013–2016 and the Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0009)—cofinanced by the European Development Regional Fund “A Way to Achieve Europe”—by Operative Program Intelligent Growth 2014-2020 and grants FIS PI17/00159 from the Instituto de Salud Carlos III and SAF2015-72793-EXP from the Spanish Ministry of Science and Competitiveness (MINECO)-FEDER. E.C.-S. was the recipient of a PFIS predoctoral research fellowship (FI18/00036) cofinanced by the Instituto de Salud Carlos III and the European Social Fund. I.C., A.C.-O., and M.T.-P. are funded by projects of the 581 European Research Council (ERC) (638553-TB-ACCELERATE) and Ministerio de Economía y Competitividad research grant SAF2016-77346-R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Contaminant DNA in bacterial sequencing experiments is a major source of false genetic variability

  • Goig, Galo A.
  • Blanco, Silvia
  • Garcia-Basteiro, Alberto L.
  • Comas, Iñaki
[Background] Contaminant DNA is a well-known confounding factor in molecular biology and in genomic repositories. Strikingly, analysis workflows for whole-genome sequencing (WGS) data commonly do not account for errors potentially introduced by contamination, which could lead to the wrong assessment of allele frequency both in basic and clinical research., [Results] We used a taxonomic filter to remove contaminant reads from more than 4000 bacterial samples from 20 different studies and performed a comprehensive evaluation of the extent and impact of contaminant DNA in WGS. We found that contamination is pervasive and can introduce large biases in variant analysis. We showed that these biases can result in hundreds of false positive and negative SNPs, even for samples with slight contamination. Studies investigating complex biological traits from sequencing data can be completely biased if contamination is neglected during the bioinformatic analysis, and we demonstrate that removing contaminant reads with a taxonomic classifier permits more accurate variant calling. We used both real and simulated data to evaluate and implement reliable, contamination-aware analysis pipelines., [Conclusion] As sequencing technologies consolidate as precision tools that are increasingly adopted in the research and clinical context, our results urge for the implementation of contamination-aware analysis pipelines. Taxonomic classifiers are a powerful tool to implement such pipelines., This work was funded by projects of the European Research Council (ERC) (638553-TB-ACCELERATE) and Ministerio de Economía y Competitividad (Spanish Government) research grant SAF2016-77346-R (to IC), SAF2017-92345-EXP (to IC), and BES-2014-071066 (to GAG).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1β production

  • Sousa, Jeremy
  • Cá, Baltazar
  • Maceiras, Ana Raquel
  • Simoes-Costa, Luisa
  • Fonseca, Kaori L.
  • Fernandes, Ana Isabel
  • Ramos, Angélica
  • Carvalho, Teresa
  • Barros, Leandro
  • Magalhães, Carlos
  • Chiner-Oms, Álvaro
  • Machado, Henrique
  • Veiga, Maria Isabel
  • Singh, Albel
  • Pereira, Rui
  • Amorim, António
  • Vieira, Jorge
  • Vieira, Cristina P.
  • Bhatt, Apoorva
  • Rodrigues, Fernando
  • Rodrigues, Pedro N. S.
  • Gagneux, Sebastien
  • Gil Castro, António
  • Guimarães, João Tiago
  • Bastos, Helder Novais
  • Osório, Nuno S.
  • Comas, Iñaki
  • Saraiva, Margarida
14 páginas, 6 figuras. Supplementary information is available for this paper at https://doi.org/10.1038/s41467-020-15832-6. Sequence data are deposited on NCBI GEO database with the accession code GSE138580, Genetic diversity of Mycobacterium tuberculosis affects immune responses and clinical outcomes of tuberculosis (TB). However, how bacterial diversity orchestrates immune responses to direct distinct TB severities is unknown. Here we study 681 patients with pulmonary TB and show that M. tuberculosis isolates from cases with mild disease consistently induce robust cytokine responses in macrophages across multiple donors. By contrast, bacteria from patients with severe TB do not do so. Secretion of IL-1β is a good surrogate of the differences observed, and thus to classify strains as probable drivers of different TB severities. Furthermore, we demonstrate that M. tuberculosis isolates that induce low levels of IL-1β production can evade macrophage cytosolic surveillance systems, including cGAS and the inflammasome. Isolates exhibiting this evasion strategy carry candidate mutations, generating sigA recognition boxes or affecting components of the ESX-1 secretion system. Therefore, we provide evidence that M. tuberculosis strains manipulate host-pathogen interactions to drive variable TB severities, This work was financed by FCT-Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Inovação grant POCI-01-0145-FEDER-028955 (to M.S.) and by the Northern Portugal Regional Operational Program (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER) (NORTE-01-0145-FEDER-000013, to M.I.V., F.R., A.G.C., and N.S.O.). I.C.acknowledges the support of Ministerio de Ciencia, Innovación y Universidades (SAF2016-77346-R) and the European Research Council (638553-TB-ACCELERATE). H.N.B. acknowledges the support of Bolsa D. Manuel de Mello and of the Portuguese Society for Pneumology; A.B. and M.S. were also recipients of an International Exchanges Grant from the Royal Society. J.S. is funded by a research fellow NORTE-01-0145-FEDER-000012; B.C. and K.L.F. are funded by FCT Ph.D scholarships SFRH/BD/114403/2016 and SFRH/BD/114405/2016, respectively; M.I.V. is funded by FCT through DL 57/2016 (CRP) and MS through Estimulo Individual ao Emprego Científico. We thank the excellent support from the i3S scientific platforms, namely Animal facility, Advanced Light Microscopy, and BioSciences Screening, member of the national infrastructure PPBI-Portuguese Platform of Bioimaging (PPBI-POCI-01-0145-FEDER-022122)and Genomics (GenCore) part of the GenomePT project (POCI-01-0145-FEDER022184), supported by COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Lisboa Portugal Regional Operational Programme (Lisboa2020), Algarve Portugal Regional Operational Programme (CRESC Algarve2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), and by Fundação para a Ciência e a Tecnologia (FCT)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel
  • Shubladze, Natalia
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex
  • Vilaplana, Cristina
  • Gagneux, Sebastien
  • Kempker, Russell R
  • Vashakidze, Sergo
  • Comas, Iñaki
11 páginas, 5 figuras, 1 tabla, Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples., The authors were supported by projects SAF2016-77346-R and PID2019-104477RB-I00 awarded to IC and the grant BES-2017-079656 awarded to MM by the Spanish Ministry of Economy and Competitiveness and Ministry of Science, the ERC project 638553-TBACCELERATE awarded to IC, Spanish Government-FEDER Funds through CV contract CPII18/00031 and grant PI16/01511, and Generalitat Valencia Grant to I.C. (code PROMETEO/2020/012). The grant providers played no part in study design, data collection, and analysis, or the preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An evolutionary functional genomics approach identifies novel candidate regions involved in isoniazid resistance in Mycobacterium tuberculosis

  • Furió, Victoria
  • Moreno-Molina, Miguel
  • Chiner-Oms, Álvaro
  • Villamayor, Luis M.
  • Torres-Puente, Manuela
  • Comas, Iñaki
12 páginas, 4 figuras, 1 tabla, Efforts to eradicate tuberculosis are hampered by the rise and spread of antibiotic resistance. Several large-scale projects have aimed to specifically link clinical mutations to resistance phenotypes, but they were limited in both their explanatory and predictive powers. Here, we combine functional genomics and phylogenetic associations using clinical strain genomes to decipher the architecture of isoniazid resistance and search for new resistance determinants. This approach has allowed us to confirm the main target route of the antibiotic, determine the clinical relevance of redox metabolism as an isoniazid resistance mechanism and identify novel candidate genes harboring resistance mutations in strains with previously unexplained isoniazid resistance. This approach can be useful for characterizing how the tuberculosis bacilli acquire resistance to new antibiotics and how to forestall them., This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programs 638553 (TB-ACCELERATE), SAF2016-77346-R from Ministerio de Economía y Competitividad (Spanish Government) and AICO/2018/113 from Generalitat Valenciana (to I.C.). M.M.-M. is recipient of a FPI grant from the Ministerio de Economía y Competitividad (Spanish Government, code BES-2017-079656). V.F. was recipient of a post-doctoral research grant from the Ministerio de Economía y Competitividad (Spanish Government, code FPDI-2013-18757). Action cofinanced by the European Union through the Operational Program of European Regional Development Fund (ERDF) of Valencia Region (Spain) 2014-2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics

  • Cancino-Muñoz, Irving
  • López, Mariana G.
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borras, Rafael
  • Borras-Manez, Maria
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colijn, Caroline
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodriguez, Oscar
  • Garcia-Garcia, Francisco
  • Gil-Brusola, Ana
  • Gimeno, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Barbara
  • Gonzales-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • Comas, Iñaki
23 páginas, 4 figuras, 1 tabla., Transmission is a driver of tuberculosis (TB) epidemics in high-burden regions, with assumed negligible impact in low-burden areas. However, we still lack a full characterization of transmission dynamics in settings with similar and different burdens. Genomic epidemiology can greatly help to quantify transmission, but the lack of whole genome sequencing population-based studies has hampered its application. Here, we generate a population-based dataset from Valencia region and compare it with available datasets from different TB-burden settings to reveal transmission dynamics heterogeneity and its public health implications. We sequenced the whole genome of 785 Mycobacterium tuberculosis strains and linked genomes to patient epidemiological data. We use a pairwise distance clustering approach and phylodynamic methods to characterize transmission events over the last 150 years, in different TB-burden regions. Our results underscore significant differences in transmission between low-burden TB settings, i.e., clustering in Valencia region is higher (47.4%) than in Oxfordshire (27%), and similar to a high-burden area as Malawi (49.8%). By modeling times of the transmission links, we observed that settings with high transmission rate are associated with decades of uninterrupted transmission, irrespective of burden. Together, our results reveal that burden and transmission are not necessarily linked due to the role of past epidemics in the ongoing TB incidence, and highlight the need for in-depth characterization of transmission dynamics and specifically tailored TB control strategies., European Research Council 638553-TB-ACCELERATE; European Research Council 101001038-TBRECONNECT; Ministerio de Ciencia e Innovación SAF2016-77346-R, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

China's tuberculosis epidemic stems from historical expansion of four strains of Mycobacterium tuberculosis

  • Liu, Qingyun
  • Ma, Aijing
  • Wei, Lanhai
  • Pang, Yu
  • Wu, Beibei
  • Luo, Tao
  • Zhou, Yang
  • Zheng, Hong-Xiang
  • Jiang, Qi
  • Gan, Mingyu
  • Zuo, Tianyu
  • Liu, Mei
  • Yang, Chongguang
  • Jin, Li
  • Comas, Iñaki
  • Gagneux, Sebastien
  • Zhao, Yanlin
  • Pepperell, Caitlin S.
  • Gao, Qian
11 páginas, 6 figuras, 2 tablas. Accesible en PubMedCentral: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295914/, A small number of high-burden countries account for the majority of tuberculosis cases worldwide. Detailed data are lacking from these regions. To explore the evolutionary history of Mycobacterium tuberculosis in China-the country with the third highest tuberculosis burden-we analysed a countrywide collection of 4,578 isolates. Little genetic diversity was detected, with 99.4% of the bacterial population belonging to lineage 2 and three sublineages of lineage 4. The deeply rooted phylogenetic positions and geographic restriction of these four genotypes indicate that their populations expanded in situ following a small number of introductions to China. Coalescent analyses suggest that these bacterial subpopulations emerged in China around 1,000 years ago, and expanded in parallel from the twelfth century onwards, and that the whole population peaked in the late eighteenth century. More recently, sublineage L2.3, which is indigenous to China and exhibited relatively high transmissibility and extensive global dissemination, came to dominate the population dynamics of M. tuberculosis in China. Our results indicate that historical expansion of four M. tuberculosis strains shaped the current tuberculosis epidemic in China, and highlight the long-term genetic continuity of the indigenous M. tuberculosis population., This work was supported by the Natural Science Foundation of China (91631301 and 81661128043 to Q.G. and 81701975 to Q.L.). C.S.P. was supported by the National Institutes of Health (grant 1R01AI113287-01A1). S.G. was supported by the Swiss National Science Foundation (grants IZRJZ3_164171, 310030_166687, IZLSZ3_170834 and CRSII5_177163). This work was also supported by MINECO research grant SAF2016-77346-R (to I.C.), the European Research Council (638553-TB-ACCELERATE to I.C.), the National Science and Technology Major Project of China (2017ZX10201302 to Q.G., 2018ZX10103001 to Y.Z.), the Sanming Project of Medicine in Shenzhen (SZSM201611030 to Q.G.), JSGG20170413142559220 (to Q.G.), and National Basic Research programme of China (2014CB744403 to Y.Z.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dynamics of Xpert MTB/RIF Ultra results in follow-up sputum samples during the first month of TB treatment

  • Mambuque, E.
  • Munguambe, S.
  • Suñer, C.
  • Gomes, N.
  • Saavedra, B.
  • Verstraeten, R.
  • Pérez-Vázquez, S.
  • Vubil, D.
  • Manjate, P.
  • Banzima, C.
  • Fernández-Escobar, C.
  • Moreno-Molina, Miguel
  • López, Mariana G.
  • Comas, Iñaki
  • Nguenha, D.
  • García-Basteiro, Alberto L.
3 páginas, Ministerio de Economía y Competitividad SAF2016-77346-R, Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mycobacterium tuberculosis Acquires Limited Genetic Diversity in Prolonged Infections, Reactivations and Transmissions Involving Multiple Hosts

  • Herranz, Marta
  • Pole, Ilva
  • Ozere, Iveta
  • Chiner-Oms, Álvaro|||0000-0002-0463-0101
  • Martínez-Lirola, Miguel
  • Pérez-García, Felipe|||0000-0002-4885-4334
  • Gijon, Paloma|||0000-0002-5011-1927
  • Serrano, María Jesús Ruiz
  • Romero, Laura Clotet
  • Cuevas, Oscar|||0000-0001-7999-7701
  • Comas, I.|||0000-0001-5504-9408
  • Bouza, Emilio
  • Pérez-Lago, Laura
  • García-de-Viedma, Darío
Background: Mycobacterium tuberculosis (MTB) has limited ability to acquire variability. Analysis of its microevolution might help us to evaluate the pathways followed to acquire greater infective success. Whole-genome sequencing (WGS) in the analysis of the transmission of MTB has elucidated the magnitude of variability in MTB. Analysis of transmission currently depends on the identification of clusters, according to the threshold of variability (<5 SNPs) between isolates. Objective: We evaluated whether the acquisition of variability in MTB, was more frequent in situations which could favor it, namely intrapatient, prolonged infections or reactivations and interpatient transmissions involving multiple sequential hosts. Methods: We used WGS to analyze the accumulation of variability in sequential isolates from prolonged infections or translations from latency to reactivation. We then measured microevolution in transmission clusters with prolonged transmission time, high number of involved cases, simultaneous involvement of latency and active transmission. Results: Intrapatient and interpatient acquisition of variability was limited, within the ranges expected according to the thresholds of variability proposed, even though bursts of variability were observed. Conclusions: The thresholds of variability proposed for MTB seem to be valid in most circumstances, including those theoretically favoring acquisition of variability. Our data point to multifactorial modulation of microevolution, although further studies are necessary to elucidate the factors underlying this modulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel|||0000-0003-0305-4445
  • Shubladze, Natalia|||0000-0003-0580-9629
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela|||0000-0002-8352-180X
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex|||0000-0003-4190-9045
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Gagneux, Sebastien|||0000-0001-7783-9048
  • Kempker, Russell R.
  • Vashakidze, Sergo
  • Comas, I.|||0000-0001-5504-9408
Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples. Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. Here, Moreno-Molina et al. analyse sputum and surgical resections from tuberculosis patients, showing that the magnitude of polyclonal infections can be underestimated when only testing sputum samples.